Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
724studies shown
Showing 601-625 of 724
RecruitingNCT07565428

Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand whether a medication treatment can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Minerva Neurosciences
Condition
Schizophrenia
RecruitingNCT07559084

Multi-target TMS for Schizophrenia Negative Symptoms

This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 16 Years to 45 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia
RecruitingNCT07557381

The Effect of Game-Based Intervention on the Cognition of Schizophrenia Patients

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can better support energy, concentration, and everyday functioning.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia
RecruitingNCT07557368

Effects of Gamified Rehabilitation on Cognitive and Psychosocial Outcomes in Inpatients With Schizophrenia

This study exists to understand how psychoeducation, a guided learning and support program, holds up over time after the earliest research stage. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia
RecruitingNCT05778591

Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Schizophrenia
RecruitingNCT01730781

Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

This study exists to see whether smoking support or smoking-related treatment is workable and worth testing more broadly. Researchers are trying to understand what smoking support or smoking-related treatment can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
RecruitingNCT06969755

Biomarkers to Enhance Early Schizophrenia Treatment

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
Canada, United States
Sponsor
Northwell Health
Condition
Schizophrenia
RecruitingNCT06649552

French Validation of Schizophrenia Proneness Instrument- Child Youth

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 12 Years to 17 Years
Countries
France
Sponsor
Centre Psychothérapique de Nancy
Condition
Schizophrenia
RecruitingNCT01409109

Database Registry for Neural Network Biomarkers in Psychosis

This study exists to learn from real-world information that can show how a digital app or remote support tool fits into care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Schizophrenia
RecruitingNCT06947941

A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)

This study exists to explore whether this type of care could improve care and understanding. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

SchizophreniaOtherFrom 55 Years to 90 Years
Countries
Australia, Canada, Japan, United Kingdom, United States
Sponsor
Bristol-Myers Squibb
Condition
Schizophrenia
RecruitingNCT05796401

Efficiency of a Composite Personalised Care on Functional Outcome in Early Psychosis

This study exists to see whether psychoeducation, a guided learning and support program, can play a useful role in care. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 15 Years to 30 Years
Countries
France
Sponsor
Centre Hospitalier St Anne
Condition
Schizophrenia
RecruitingNCT05973110

Examining the Efficacy of a Virtual Reality Cognitive Remediation Program for People Living With Psychosis

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Canada
Sponsor
The Royal Ottawa Mental Health Centre
Condition
Schizophrenia
RecruitingNCT04478838

"Extended" (Alternate Day) Antipsychotic Dosing

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

SchizophreniaOtherOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
RecruitingNCT04226898

Synbiotic Compound to Reduce Symptoms of Schizophrenia

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Sheppard Pratt Health System
Condition
Schizophrenia
RecruitingNCT04887792

Acetazolamide for Treatment Resistant Schizophrenia

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
India, United States
Sponsor
Vishwajit Nimgaonkar, MD PhD
Condition
Schizophrenia
RecruitingNCT07509125

Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders

This study exists to see whether blood tests and biological markers can make care clearer and more responsive. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 90 Years
Countries
Belgium
Sponsor
Universitaire Ziekenhuizen KU Leuven
Condition
Schizophrenia
RecruitingNCT03971487

Ocrelizumab for Psychosis by Autoimmunity

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand what this type of care can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
United States
Sponsor
The Methodist Hospital Research Institute
Condition
Schizophrenia
RecruitingNCT04629352

Effect of Neuroplasticity Modulation in tDCS Treatment Response Among Schizophrenia Patients With Auditory Hallucination

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
India
Sponsor
National Institute of Mental Health and Neuro Sciences, India
Condition
Schizophrenia
RecruitingNCT06118268

iTBS to Enhance Social Cognition in People With Psychosis

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 39 Years
Countries
United States
Sponsor
Northwell Health
Condition
Schizophrenia
RecruitingNCT06978803

HYEEG Discourse in Psychosis: A Neurobehavioural Study

This study exists to see whether questionnaires and follow-up reports can make care clearer and more responsive. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Canada
Sponsor
Douglas Mental Health University Institute
Condition
Schizophrenia
RecruitingNCT06345963

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)

This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Schizophrenia
RecruitingNCT06978894

Predicting Psychotic Relapse Using Speech-Based Early Detection

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 16 Years
Countries
Canada
Sponsor
Douglas Mental Health University Institute
Condition
Schizophrenia
RecruitingNCT06386588

The Effects of Auditory Stimulation During Sleep on Brain Networks in Schizophrenia

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Schizophrenia
RecruitingNCT06958341

Neuroimmunology Registry and Biobank

This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.

SchizophreniaOther
Countries
Germany
Sponsor
Charite University, Berlin, Germany
Condition
Schizophrenia